Evidence map›Paper›PMID 27030402›Full record

ArticleMolecular imaging2016

The Effects of Physiological and Methodological Determinants on 18F-FDG Mouse Brain Imaging Exemplified in a Double Transgenic Alzheimer Model.

Steven Deleye, Ann-Marie Waldron, Jill C Richardson, Mark Schmidt, Xavier Langlois, Sigrid Stroobants, Steven Staelens

Open access · goldAbstract read
In one paragraph

Article in Molecular imaging, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. In-ovo imaging using ostrich eggs: biodistribution of F-18-FDG in ostrich embryos.Experimental biology and medicine (Maywood, N.J.) · 2025
    Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Longitudinal [EJNMMI research · 2020
    Article
  11. Frontiers in medicine · 2020
    Article
  12. Prognostic value ofScientific reports · 2019
    Article
  13. Article
  14. Article
  15. Frontiers in medicine · 2019
    Review
  16. Article
  17. Frontiers in aging neuroscience · 2018
    Article
  18. Brain energy metabolism and neuroinflammation in ageing APP/PS1-21 mice using longitudinalJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2017
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Steven DeleyeMolecular Imaging Center Antwerp, University of Antwerp, Antwerp, Belgium.
Ann-Marie WaldronMolecular Imaging Center Antwerp, University of Antwerp, Antwerp, Belgium.
Jill C RichardsonR&D China UK Group, GlaxoSmithKline, Stevenage, United Kingdom.
Mark SchmidtNeuroscience Department, Janssen Pharmaceutica NV, Beerse, Belgium.
Xavier LangloisNeuroscience Department, Janssen Pharmaceutica NV, Beerse, Belgium.
Sigrid StroobantsMolecular Imaging Center Antwerp, University of Antwerp, Antwerp, Belgium Nuclear Medicine Department, University Hospital Antwerp, Antwerp, Belgium.
Steven StaelensMolecular Imaging Center Antwerp, University of Antwerp, Antwerp, Belgium Steven.Staelens@uantwerpen.be.
University of Antwerp · BEJanssen (Belgium) · BEAntwerp University Hospital · BEGlaxoSmithKline (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn this study, the influence of physiological determinants on 18F-fluoro-d-glucose ((18)F-FDG) brain uptake was evaluated in a mouse model of Alzheimer disease. MATERIALS AND

methodsTASTPM (Tg) and age-matched C57BL/6 J (WT) mice were fasted for 10 hours, while another group was fasted for 20 hours to evaluate the effect of fasting duration. The effect of repeatedly scanning was evaluated by scanning Tg and WT mice at days 1, 4, and 7. Brain (18)F-FDG uptake was evaluated in the thalamus being the most indicative region. Finally, the cerebellum was tested as a reference region for the relative standard uptake value (rSUV).

resultsWhen correcting the brain uptake for glucose, the effect of different fasting durations was attenuated and the anticipated hypometabolism in Tg mice was demonstrated. Also, with repeated scanning, the brain uptake values within a group and the hypometabolism of the Tg mice only remained stable over time when glucose correction was applied. Finally, hypometabolism was also observed in the cerebellum, yielding artificially higher rSUV values for Tg mice.

conclusionCorrections for blood glucose levels have to be applied when semiquantifying (18)F-FDG brain uptake in mouse models for AD. Potential reference regions for normalization should be thoroughly investigated to ensure that they are not pathologically affected also by afferent connections.

Indexed as

Alzheimer DiseaseAnimalsBlood GlucoseCerebellumDisease Models, AnimalFastingFluorodeoxyglucose F18HumansMiceMice, TransgenicNeuroimagingPositron-Emission TomographyRadiopharmaceuticalsThalamusBlood GlucoseFluorodeoxyglucose F18Radiopharmaceuticals18F-FDGAlzheimerbrain PETmouseSUV

Identifiers

PMID27030402
PMCPMC5470082
OpenAlexW2341208655

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.